Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2020

Open Access 01-06-2020 | Endoscopy | Case Report

Pill-induced esophagitis caused by ingesting excessive caffeine tablets

Authors: Jun Miyata, Yoshiyuki Ito, Shigeji Ito

Published in: Clinical Journal of Gastroenterology | Issue 3/2020

Login to get access

Abstract

A 19-year-old woman with suicidal thoughts consumed 24 anhydrous caffeine tablets and was admitted to our hospital. After being discharged from the hospital, her oral intake remained impaired because of retrosternal pain and she was readmitted. An upper gastrointestinal endoscopy revealed diffuse ulcers throughout the mid-to-lower esophagus; the patient was diagnosed with caffeine-induced esophagitis. She recovered soon after conservative treatment. A follow-up endoscopy performed 1 month after the patient was discharged showed that the ulcers had healed. This case highlights the risk of esophageal injuries after ingesting excessive caffeine tablets, which were sold as dietary supplement without a prescription. Our experience indicates that endoscopic surveillance is advisable to prevent severe complications if a patient presents with esophageal symptoms suggestive of chemical esophagitis.
Literature
1.
go back to reference Kamijo Y, Takai M, Fujita Y, et al. A retrospective study on the epidemiological and clinical features of emergency patients with large or massive consumption of caffeinated supplements or energy drinks in Japan. Intern Med. 2018;57:2141–6.CrossRefPubMedPubMedCentral Kamijo Y, Takai M, Fujita Y, et al. A retrospective study on the epidemiological and clinical features of emergency patients with large or massive consumption of caffeinated supplements or energy drinks in Japan. Intern Med. 2018;57:2141–6.CrossRefPubMedPubMedCentral
2.
go back to reference Kikendall JW, Friedman AC, Oyewole MA, et al. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci. 1983;28:174–82.CrossRefPubMed Kikendall JW, Friedman AC, Oyewole MA, et al. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci. 1983;28:174–82.CrossRefPubMed
3.
go back to reference Zografos GN, Georgiadou D, Thomas D, et al. Drug-induced esophagitis. Dis Esophagus. 2009;22:633–7.CrossRefPubMed Zografos GN, Georgiadou D, Thomas D, et al. Drug-induced esophagitis. Dis Esophagus. 2009;22:633–7.CrossRefPubMed
4.
go back to reference De Petris G, Caldero SG, Chen L, et al. Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II). Int J Surg Pathol. 2014;22:202–11.CrossRefPubMed De Petris G, Caldero SG, Chen L, et al. Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II). Int J Surg Pathol. 2014;22:202–11.CrossRefPubMed
6.
go back to reference Gopal P, Gibson JA, Lisovsky M, et al. Unique causes of esophageal inflammation: a histopathologic perspective. Ann N Y Acad Sci. 2018;1434:219–26.CrossRefPubMed Gopal P, Gibson JA, Lisovsky M, et al. Unique causes of esophageal inflammation: a histopathologic perspective. Ann N Y Acad Sci. 2018;1434:219–26.CrossRefPubMed
7.
go back to reference Iwamoto F, Sato T, Enomoto N. A drug-induced esophageal ulcer caused by caffeine. Endoscopia Digestiva. 2014;26:1690–1 (in Japanese). Iwamoto F, Sato T, Enomoto N. A drug-induced esophageal ulcer caused by caffeine. Endoscopia Digestiva. 2014;26:1690–1 (in Japanese).
8.
go back to reference Yanagisawa M, Matsuda K, Moriguchi T, et al. Oumonkin yuukai to chihatsusei shokudou kaiyou wo kitashita juushou kafein chuudoku no 1 rei. (A case report of severe caffeine intoxication associated with rhabdomyolysis and late esophageal stenosis.). J Jpn Assoc Acute Med. 2014;25:564 (in Japanese). Yanagisawa M, Matsuda K, Moriguchi T, et al. Oumonkin yuukai to chihatsusei shokudou kaiyou wo kitashita juushou kafein chuudoku no 1 rei. (A case report of severe caffeine intoxication associated with rhabdomyolysis and late esophageal stenosis.). J Jpn Assoc Acute Med. 2014;25:564 (in Japanese).
9.
go back to reference Nitta A, Arakawa J, Yamakage M, et al. Pneumomediastinum and acute esophageal mucosal lesion caused by caffeine intoxication. J Jpn Assoc Acute Med. 2018;29:196–201 (in Japanese). Nitta A, Arakawa J, Yamakage M, et al. Pneumomediastinum and acute esophageal mucosal lesion caused by caffeine intoxication. J Jpn Assoc Acute Med. 2018;29:196–201 (in Japanese).
10.
go back to reference Yasaka K, Okajima M, Yamagishi T, et al. Caffeine chuudoku ni gappeishita tokuhatsusei juukaku kishu no 1 rei. (A case report of idiopathic mediastinal emphysema associated with caffeine intoxication.). J Jpn Soc Emerg Med. 2013;16:131–5 (in Japanese). Yasaka K, Okajima M, Yamagishi T, et al. Caffeine chuudoku ni gappeishita tokuhatsusei juukaku kishu no 1 rei. (A case report of idiopathic mediastinal emphysema associated with caffeine intoxication.). J Jpn Soc Emerg Med. 2013;16:131–5 (in Japanese).
11.
go back to reference Kikendall JW. Pill esophagitis. Esophageal Gastric Dis. 1999;28:298–305. Kikendall JW. Pill esophagitis. Esophageal Gastric Dis. 1999;28:298–305.
12.
go back to reference Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf. 2000;22:237–49.CrossRefPubMed Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf. 2000;22:237–49.CrossRefPubMed
13.
go back to reference Zhang Y, Tong Y, Wang W, et al. Chest pain from pill-induced esophagitis: a rare side effect of ascorbic acid. SAGE Open Med Case Rep. 2018;6:20503. Zhang Y, Tong Y, Wang W, et al. Chest pain from pill-induced esophagitis: a rare side effect of ascorbic acid. SAGE Open Med Case Rep. 2018;6:20503.
14.
go back to reference Shaikh YM, Khan AH, Rao N, et al. Phyllocontin (theophylline) induced esophagitis. J Pak Med Assoc. 1993;43:183.PubMed Shaikh YM, Khan AH, Rao N, et al. Phyllocontin (theophylline) induced esophagitis. J Pak Med Assoc. 1993;43:183.PubMed
15.
go back to reference Fredholm BB. Gastrointestinal and metabolic effects of methylxanthines. Prog Clin Biol Res. 1984;158:331–54.PubMed Fredholm BB. Gastrointestinal and metabolic effects of methylxanthines. Prog Clin Biol Res. 1984;158:331–54.PubMed
16.
go back to reference Boley SJ, Allen AC, Schultz L, et al. Potassium-induced lesions of the small bowel I. Clinical aspects. JAMA. 1965;193:997–1000.CrossRefPubMed Boley SJ, Allen AC, Schultz L, et al. Potassium-induced lesions of the small bowel I. Clinical aspects. JAMA. 1965;193:997–1000.CrossRefPubMed
17.
18.
go back to reference Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.CrossRefPubMed Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.CrossRefPubMed
19.
go back to reference Beauchamp GA, Johnson AR, Crouch BI, et al. A retrospective study of clinical effects of powdered caffeine exposures reported to three US poison control centers. J Med Toxicol. 2016;12:295–300.CrossRefPubMedPubMedCentral Beauchamp GA, Johnson AR, Crouch BI, et al. A retrospective study of clinical effects of powdered caffeine exposures reported to three US poison control centers. J Med Toxicol. 2016;12:295–300.CrossRefPubMedPubMedCentral
20.
go back to reference Hey H, Jørgensen F, Sørensen K, et al. Oesophageal transit of six commonly used tablets and capsules. Br Med J. 1982;285:1717–9.CrossRef Hey H, Jørgensen F, Sørensen K, et al. Oesophageal transit of six commonly used tablets and capsules. Br Med J. 1982;285:1717–9.CrossRef
21.
22.
go back to reference Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305–13.CrossRefPubMedPubMedCentral Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305–13.CrossRefPubMedPubMedCentral
23.
go back to reference Gurvits GE, Cherian K, Shami MN, et al. Black esophagus: new insights and multicenter international experience in 2014. Dig Dis Sci. 2015;60:444–53.CrossRefPubMed Gurvits GE, Cherian K, Shami MN, et al. Black esophagus: new insights and multicenter international experience in 2014. Dig Dis Sci. 2015;60:444–53.CrossRefPubMed
24.
go back to reference Banerjee P, Ali Z, Levine B, et al. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59:865–8.CrossRefPubMed Banerjee P, Ali Z, Levine B, et al. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59:865–8.CrossRefPubMed
25.
go back to reference Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–4.CrossRefPubMed Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–4.CrossRefPubMed
26.
go back to reference Poussel M, Kimmoun A, Levy B, et al. Fatal cardiac arrhythmia following voluntary caffeine overdose in an amateur body-builder athlete. Int J Cardiol. 2013;166:e41–e4242.CrossRefPubMed Poussel M, Kimmoun A, Levy B, et al. Fatal cardiac arrhythmia following voluntary caffeine overdose in an amateur body-builder athlete. Int J Cardiol. 2013;166:e41–e4242.CrossRefPubMed
28.
go back to reference Lelo A, Kjellen G, Birkett DJ, et al. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J Pharmacol Exp Ther. 1989;248:315–9.PubMed Lelo A, Kjellen G, Birkett DJ, et al. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J Pharmacol Exp Ther. 1989;248:315–9.PubMed
Metadata
Title
Pill-induced esophagitis caused by ingesting excessive caffeine tablets
Authors
Jun Miyata
Yoshiyuki Ito
Shigeji Ito
Publication date
01-06-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 3/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01055-w

Other articles of this Issue 3/2020

Clinical Journal of Gastroenterology 3/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.